All About Multiple Sclerosis

More MS news articles for February 2003

Abbott Working On More Monoclonal Antibodies, Histamine And Nicotinic Drugs

Feb 18, 2003
Reuters Health

Abbott Laboratories on Monday said clinical trials of J695, a human monoclonal antibody that neutralises interleukin-12, are about to start in multiple sclerosis in addition to the previously announced trials in rheumatoid arthritis and Crohn's disease.

© Copyright 2003, Reuters Health